PET has already gained significant momentum in recent years. Now, researchers are pointing to another possible use for the popular imaging modality: assessing carotid artery atherosclerosis.
Last month, the Department of Commerce launched an investigation into the importing of such items, seeking to determine the impact on national security.
Authorities granted 510(k) clearance for Brain Health in late September, with the Los Angeles-based imaging center operator touting the decision Tuesday.
ACR’s board has chosen Hedvig Hricak, MD, PhD, and Debra Monticciolo, MD, as its next honorees, who will be recognized at the organization’s 2026 annual meeting in May.
It is estimated that less than 20% of eligible patients in the U.S. adhere to LCS recommendations, despite numerous studies highlighting the exam’s effectiveness.
The update eliminates the requirement for a physician to be on-site and now allows techs to perform venipuncture and conduct contrast administration under remote supervision.
In this Radiology Business opinion piece, Rachel Bowne, senior manager of imaging at AdventHealth Apopka, Florida, discusses the evolving titles of technologists and how leaders must change their thinking about the profession.
Gaps in coverage result in individuals paying anywhere from $234 for a follow-up diagnostic mammogram to over $1,000 for a breast MRI, Komen estimates.
Many people with low bone mineral density are not aware of their condition because they fail to get screened through DXA or are not eligible due to age.
PET has already gained significant momentum in recent years. Now, researchers are pointing to another possible use for the popular imaging modality: assessing carotid artery atherosclerosis.
"PET has changed the practice of nuclear medicine in general and I think it is going to revitalize the practice of cardiology," Marcelo Di Carli, MD, told Cardiovascular Business. He noted that more practices seem interested in implementing PET than ever before.
“Multimodality imaging in cardio-oncology is something many of us in the field are truly excited about," Daniel Addison, MD, told Cardiovascular Business. He noted that modalities other than echocardiography are starting to play a much larger role in the treatment of these patients.
